The report provides a detailed analysis essential for establishing a Uricase production plant. It encompasses all critical aspects necessary for Uricase production, including the cost of Uricase production, Uricase plant cost, Uricase production costs, and the overall Uricase production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Uricase production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Uricase, also known as urate oxidase, is primarily used management of elevated uric acid levels. It functions by catalyzing the oxidation of uric acid, reducing its concentration in the serum. It is used in the treatment of Hyperuricemia caused by high levels of uric acid in the blood by reducing its symptoms and preventing flare-ups. Its pegylated form is used in the treatment of chronic gout in patients who are not responsive to other medications.
Uricase is utilised in treating rapid cell lysis in patients undergoing chemotherapy, thus reducing the risk of kidney damage. It is being explored for enzyme replacement therapy for patients with genetic disorders. It is also used in laboratory settings for the measurement of uric acid levels in blood and urine. It is also used in research to study purine metabolism, oxidative stress, and the biochemical pathways involved in uric acid degradation.
The market of Uricase is mainly driven by its key role in managing elevated uric acid levels in the blood. Its effective use in treating Hyperuricemia and gout leads to its growing demand among patients. Uricase is also utilized in the management of tumor lysis syndrome. Its potential for enzyme replacement therapy in patients with genetic disorders further drives interest in its procurement for developing targeted treatments.
It is employed in laboratory settings for measuring uric acid levels in blood and urine, making it valuable for monitoring and managing conditions related to uric acid metabolism. Industrial uricase procurement is driven by its important role in managing elevated uric acid levels in the blood, along with its use in laboratory diagnostics and research.
Raw Material for Uricase Production
According to the Uricase production plant project report, the key raw materials used in the production of Uricase include Microbial Strains- E. coli cells -Culture Media.
Manufacturing Process of Uricase
The extensive Uricase production cost report consists of the following major industrial production process:
- From Microbial Strains, E. coli cells and culture media: The industrial production process of Uricase consists of several key steps. First, uricase sequences are identified from microbial sources. After that, these sequences are cloned into expression vectors for E. coli under controlled conditions to maximize yield. Then, the E. coli cells are lysed, and the soluble Uricase is purified from insoluble aggregates through centrifugation. The Uricase is tested to evaluate its efficacy to ensure patient safety.
Uricase is a slightly green color crystalline powder. It has a molecular weight of 32 kDa for each subunit. It is almost insoluble in water. Its isoelectric point is 5.6. It has an alpha-helix content of 12%. Its specific activity is about 25.8 units per mg of protein. It has three cysteines. It is stable at pH levels between 7.0 and 11.0 and temperatures below 55°C. Optimal activity is observed at pH 8.5 and 45°C. All these physical and chemical properties make Uricase valuable for applications in clinical analysis, particularly for determining uric acid levels.
